DK52487D0 - Ophthalmisk anvendelse af quinolon- og naphthyri- dinforbindelser - Google Patents

Ophthalmisk anvendelse af quinolon- og naphthyri- dinforbindelser

Info

Publication number
DK52487D0
DK52487D0 DK052487A DK52487A DK52487D0 DK 52487 D0 DK52487 D0 DK 52487D0 DK 052487 A DK052487 A DK 052487A DK 52487 A DK52487 A DK 52487A DK 52487 D0 DK52487 D0 DK 52487D0
Authority
DK
Denmark
Prior art keywords
naphthyrine
quinolon
din
compounds
ophthalmic use
Prior art date
Application number
DK052487A
Other languages
English (en)
Other versions
DK173401B1 (da
DK52487A (da
Inventor
Thomas Frederick Mich
Carl Lewis Heifetz
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of DK52487D0 publication Critical patent/DK52487D0/da
Publication of DK52487A publication Critical patent/DK52487A/da
Application granted granted Critical
Publication of DK173401B1 publication Critical patent/DK173401B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK198700524A 1986-02-03 1987-02-02 Anvendelse af en quinolon- eller naphthyridinforbindelse til fremstilling af et lægemiddel til topisk behandling af øjeninf DK173401B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/825,007 US4692454A (en) 1986-02-03 1986-02-03 Opthalmic use of quinolone antibiotics
US82500786 1986-02-03

Publications (3)

Publication Number Publication Date
DK52487D0 true DK52487D0 (da) 1987-02-02
DK52487A DK52487A (da) 1987-08-04
DK173401B1 DK173401B1 (da) 2000-09-25

Family

ID=25242879

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198700524A DK173401B1 (da) 1986-02-03 1987-02-02 Anvendelse af en quinolon- eller naphthyridinforbindelse til fremstilling af et lægemiddel til topisk behandling af øjeninf

Country Status (14)

Country Link
US (2) US4692454A (da)
EP (1) EP0235589B1 (da)
JP (1) JPS62185085A (da)
AT (1) ATE81776T1 (da)
AU (1) AU588958B2 (da)
CA (1) CA1281653C (da)
DE (1) DE3782346T2 (da)
DK (1) DK173401B1 (da)
ES (1) ES2044843T3 (da)
GR (1) GR3006180T3 (da)
IE (1) IE61017B1 (da)
NZ (1) NZ219138A (da)
PH (2) PH23722A (da)
ZA (1) ZA87164B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826985A (en) * 1986-04-25 1989-05-02 Abbott Laboratories Intermediates for preparation of racemate and optically active ofloxacin and related derivatives
US5229128A (en) * 1986-06-11 1993-07-20 Haddad Heskel M Drug delivery ophthalmic insert and method of preparing same
IL93996A0 (en) * 1989-04-04 1991-01-31 Alcon Lab Inc Pharmaceutical composition containing a liposome
WO1991009616A1 (en) * 1989-12-22 1991-07-11 Yale University Quinolone antibiotics encapsulated in lipid vesicles
US4992449A (en) * 1990-02-01 1991-02-12 American Cyanamid Company 7-(substituted)cycloalkylamino-1-(substituted)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
US5130353A (en) * 1990-03-07 1992-07-14 Ppg Industries, Inc. Method for preparing photochromic plastic article
US5185390A (en) * 1990-03-07 1993-02-09 Ppg Industries, Inc. Water strippable photochromic resin composition
JPH0725747B2 (ja) * 1990-03-16 1995-03-22 エスエス製薬株式会社 キノロンカルボン酸誘導体
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
CA2174803C (en) * 1996-04-23 2000-07-11 Jonathan P. Wong Use of liposome encapsulated ciprofloxacin as an immunotherapeutic drug
US6861411B1 (en) 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
US7056893B2 (en) * 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US6699492B2 (en) 1999-03-31 2004-03-02 Insite Vision Incorporated Quinolone carboxylic acid compositions and related methods of treatment
US6685958B2 (en) 2001-04-25 2004-02-03 Insite Vision Incorporated Quinolone carboxylic acid compositions and related methods of treatment
US6239113B1 (en) 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
JP4756674B2 (ja) * 2000-09-05 2011-08-24 株式会社サクラクレパス 塗布具
US20060046970A1 (en) * 2004-08-31 2006-03-02 Insite Vision Incorporated Topical otic compositions and methods of topical treatment of prevention of otic infections
CN102026665A (zh) * 2008-05-19 2011-04-20 爱尔康研究有限公司 含有羧基乙烯基聚合物和聚维酮聚合物的药物组合物
WO2023205415A1 (en) * 2022-04-22 2023-10-26 Mitobridge Inc. Transcription factor eb activators and uses thereof

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3963736A (en) * 1970-01-28 1976-06-15 Sumitomo Chemical Company, Limited Preparation of 1-(lower alkyl)-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acids
US3907808A (en) * 1971-05-17 1975-09-23 Sterling Drug Inc 1,4-Dihydro-4-oxo-7-pyridyl-3-quinolinecarboxylic acid derivatives
US3753993A (en) * 1971-05-17 1973-08-21 Sterling Drug Inc 1,4-dihydro-4-oxo-7-pyridyl-3-quinoline-carboxylic acid derivatives
JPS53141286A (en) * 1977-05-16 1978-12-08 Kyorin Seiyaku Kk Novel substituted quinolinecarboxylic acid
DE2808070A1 (de) * 1978-02-24 1979-08-30 Bayer Ag Verfahren zur herstellung von 4-pyridon-3-carbonsaeuren und/oder deren derivaten
JPS5845426B2 (ja) * 1978-09-29 1983-10-08 杏林製薬株式会社 置換キノリンカルボン酸誘導体
JPS5649382A (en) * 1979-09-28 1981-05-02 Dainippon Pharmaceut Co Ltd 6-fluoro-7-cyclic amino-1,8-naphthylidine derivative and its salt
JPS5746986A (en) * 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
DE3033157A1 (de) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
SE440354B (sv) * 1981-02-19 1985-07-29 Kyorin Seiyaku Kk Kinolinkarboxylsyraderivat
US4382937A (en) * 1981-02-27 1983-05-10 Dainippon Pharmaceutical Co., Ltd. Naphthyridine derivatives and their use as anti-bacterials
JPS57145862A (en) * 1981-03-06 1982-09-09 Kyorin Pharmaceut Co Ltd Quinolinecarboxylic acid derivative
US4499091A (en) * 1982-03-31 1985-02-12 Sterling Drug Inc. 1-Amino (or substituted amino)-1,4-dihydro-4-oxo-6-fluoro-7-heterylquinoline-3-carboxylic acids and their use as antibacterial agents
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
FR2559484B2 (fr) * 1983-07-06 1986-09-26 Provesan Sa Nouveau derive 7-(pyrrol-1-yl) de l'acide 1-ethyl-1,4-dihydro-4-oxo-(1,8-naphtyridin)-3-carboxylique, sa preparation et son application en tant que medicament
CS274601B2 (en) * 1983-07-27 1991-09-15 Dainippon Pharmaceutical Co Method of 1,8-naphthyridine derivative production
US4551456A (en) * 1983-11-14 1985-11-05 Merck & Co., Inc. Ophthalmic use of norfloxacin and related antibiotics
US4604401A (en) * 1984-07-20 1986-08-05 Warner-Lambert Company Antibacterial agents III
IN162769B (da) * 1984-11-13 1988-07-09 Kyorin Seiyaku Kk
JPH0670032B2 (ja) * 1984-11-22 1994-09-07 大日本製薬株式会社 アミノピロリジン誘導体、そのエステルおよびその塩
AU578793B2 (en) * 1985-02-15 1988-11-03 Dainippon Pharmaceutical Co. Ltd. Novel 1,8-naphthyridine derivatives and processes for preparation thereof
JPH0635457B2 (ja) * 1985-06-28 1994-05-11 杏林製薬株式会社 ピリドンカルボン酸誘導体およびその製造方法
JP2874664B2 (ja) * 1996-09-18 1999-03-24 日本電気株式会社 ページプリンタ

Also Published As

Publication number Publication date
DE3782346T2 (de) 1993-03-11
AU588958B2 (en) 1989-09-28
DK173401B1 (da) 2000-09-25
NZ219138A (en) 1990-03-27
ATE81776T1 (de) 1992-11-15
AU6750587A (en) 1987-08-06
ES2044843T3 (es) 1994-01-16
US4692454A (en) 1987-09-08
EP0235589A2 (en) 1987-09-09
EP0235589A3 (en) 1989-12-13
PH23722A (en) 1989-11-03
JPS62185085A (ja) 1987-08-13
EP0235589B1 (en) 1992-10-28
IE870237L (en) 1987-08-03
CA1281653C (en) 1991-03-19
DE3782346D1 (de) 1992-12-03
US4851415A (en) 1989-07-25
DK52487A (da) 1987-08-04
ZA87164B (en) 1988-07-11
PH25096A (en) 1991-02-19
GR3006180T3 (da) 1993-06-21
IE61017B1 (en) 1994-09-07

Similar Documents

Publication Publication Date Title
DK52487A (da) Ophthalmisk anvendelse af quinolon- og naphthyri- dinforbindelser
ES2056963T3 (es) Agentes antibacterianos.
NO934304L (no) Fremgangsmaate for behandling av fluoralumosilikatglass
EP0142426A3 (en) Ophthalmic formulation containing norfloxacin and related antibiotics
DE3774918D1 (de) Cancerostatisches mittel.
PT100914A (pt) Uso de compostos capazes de sofrer uma permuta mista com dissulfureto, com uma ligacao dissulfureto, no tratamento de infeccao por hiv
FI891986A0 (fi) Farmaceutiska sammansaettningar foer behandling av psoriasis.
ES2113938T3 (es) Isomeros opticos de 7-(3-(1,1-dialquilmetil-1-amino)-1-pirrolidinil)-quinolonas y naftiridonas utilizados como agentes antibacterianos.
KR870700622A (ko) 폴리시클릭퀴놀린, 나프티리딘 및 피라지노피리딘 유도체
NO880405D0 (no) Fremgangsmaate til fremstilling av 3-fenyl-7h-tiazolo-/3,2-b//1,2,4/-tiazine-7-oner.
ZA873970B (en) Pharmaceutical formulation for the treatment of bacterial infections
BR9106596A (pt) Processo para o tratamento ou profilaxia de uma infeccao associada com retrovirus,uso,composicao farmaceutica para o tratamento ou profilaxia de uma infeccao associada com retrovirus,e,composto
ES2019583B3 (es) Composicion para el tratamiento de infecciones.
NO890287D0 (no) Fremstilling av beta-laktam-antibiotika.
ATE47863T1 (de) Makrolide derivate.
FI942505A (fi) Antibakteriella aemnen
TR20828A (tr) Cam ipliginin muamelesine mahsus usul
MD347B1 (ro) Compozitie pentru tratarea lentilelor de contact
NO900862L (no) Anordning for aa lette behandlingen av for-baller.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK